Company intelligence / Profile preview

William Demant Invest

Copenhagen, Denmark

Ownership: Private
Development stage: Other

Overview

William Demant Invest is an evergreen investor and holding company owned by the William Demant Foundation, focusing on strategic investments primarily in global hearing healthcare, MedTech, diagnostics, and selected health-related markets, maintaining majority ownership in flagship companies such as Demant and Embla Medical

Therapeutic areas: OncologyNeurologyOphthalmologyOther
Modalities: Hearing Aids (Device)Diagnostics (Device)Orthopedics (Device)Radiotherapy (Device)
Industry: Investors

Partnerships

Functions as major/controlling shareholder in portfolio companies; specific partnerships occur at subsidiary level (e.g., Demant's global distribution partners)

Beyond the preview

Go deeper on William Demant Invest.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on William Demant Invest.

Explore the full profile